New DNA shots aim to stop deadly rodent virus
NCT ID NCT04333459
First seen May 29, 2026 · Last updated May 30, 2026 · Updated 1 time
Summary
This study tested two DNA vaccines designed to prevent hemorrhagic fever with renal syndrome caused by Hantaan and Puumala viruses. Healthy adults aged 18-49 received up to four doses via a needle-free jet injector. The goal was to see if the vaccines trigger a strong immune response and if a lower dose works as well as a higher one.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HANTAAN VIRUS NEPHROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Trials Center, Walter Reed Army Institute of Reserach
Silver Spring, Maryland, 20910, United States
-
Department of Clinical Trials, WRAIR
Silver Spring, Maryland, 20910, United States
Conditions
Explore the condition pages connected to this study.